Le Lézard
Classified in: Health
Subject: ACC

Medicover Raises EUR 120 Million With Inaugural Schuldschein Loan


STOCKHOLM, Oct. 2, 2019 /PRNewswire/ -- Medicover AB (publ) has successfully carried out its first Schuldschein issue (a German private placement debt instrument), with a total of EUR 120 million in Euro-denominated tranches with maturities of 5 and 7 years, at fixed and floating rates. The issue was oversubscribed and increased from the initially offered EUR 100 million.

With this transaction, Medicover was able to diversify its sources of financing and substantially expand the investor base, notably towards German, Asian and Polish institutional investors. Demand across all tranches was high, reflecting the company's good financial position.

Medicover further strengthen liquidity and make use of attractive market conditions with margins of 1.2% and 1.5% for both the fixed and floating rate tranches, in 5 and 7 years, respectively.

Landesbank Hessen-Thüringen Girozentrale (Helaba), ING Bank, and Skandinaviska Enskilda Banken AB (publ), Frankfurt Branch acted as joint arrangers on the deal.

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations

+46-703-033-272

[email protected]

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2018, Medicover had a revenue of ?672 million and 20,970 employees. For more information, go to www.medicover.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/medicover/r/medicover-raises-eur-120-million-with-inaugural-schuldschein-loan,c2923289

The following files are available for download:

https://mb.cision.com/Main/15662/2923289/1117047.pdf

Medicover raises EUR 120 million with inaugural Schuldschein loan


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: